LUCIA SANCHEZ-LEE: Open Payments
NPI 1407492853 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$654 in 30 payments from 9 companies in 2025. Trend: 2023 $554 · 2024 $303 · 2025 $654
Food & beverage: $654
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $231 |
| Amgen Inc. | 6 | $138 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $80 |
| AstraZeneca Pharmaceuticals LP | 4 | $73 |
| PFIZER INC. | 2 | $55 |
| Novo Nordisk Inc | 1 | $23 |
| Lilly USA, LLC | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $17 |
Products named: VRAYLAR, JOURNAVX, OTEZLA, UBRELVY, KRYSTEXXA, NURTEC ODT, ELIQUIS, Wegovy.
Industry payments across NV — which companies pay providers there.
